Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.5300
+0.0100 (1.92%)
At close: Aug 21, 2026, 4:00 PM EDT
0.5406
+0.0106 (2.00%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Traws Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5.02 | 3.82 | 21.34 | 20.82 | 38.76 | 55.07 |
Cash & Short-Term Investments | 5.02 | 3.82 | 21.34 | 20.82 | 38.76 | 55.07 |
Cash Growth | -61.65% | -82.10% | 2.48% | -46.28% | -29.62% | 189.46% |
Accounts Receivable | - | - | - | - | 0.03 | 0.03 |
Other Receivables | 3.45 | 3.79 | 1.77 | 0.02 | - | - |
Receivables | 3.45 | 3.79 | 1.77 | 0.02 | 0.03 | 0.03 |
Inventory | - | - | - | 0.19 | 0.1 | 0.03 |
Prepaid Expenses | 0.55 | 0.23 | 0.16 | 0.17 | 0.19 | 0.25 |
Other Current Assets | - | 0.13 | 1.69 | 1.46 | 0.27 | 0.05 |
Total Current Assets | 9.02 | 7.98 | 24.95 | 22.66 | 39.35 | 55.43 |
Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 |
Other Intangible Assets | 2.44 | 2.53 | - | - | - | - |
Other Long-Term Assets | 0 | 0.1 | 0 | 0 | 0 | 0.01 |
Total Assets | 11.47 | 10.62 | 24.96 | 22.68 | 39.37 | 55.48 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6.33 | 5.65 | 8.19 | 5.62 | 3.86 | 2.76 |
Accrued Expenses | 3.4 | 5.37 | 3.12 | 3.38 | 3.96 | 3.13 |
Current Unearned Revenue | - | - | 0.23 | 0.23 | 0.23 | 0.23 |
Other Current Liabilities | - | 0.13 | - | - | - | - |
Total Current Liabilities | 9.74 | 11.15 | 11.53 | 9.22 | 8.05 | 6.12 |
Long-Term Unearned Revenue | - | - | 2.57 | 2.79 | 3.02 | 3.24 |
Other Long-Term Liabilities | 0.04 | 0.1 | 42.49 | - | - | - |
Total Liabilities | 9.78 | 11.25 | 56.59 | 12.01 | 11.06 | 9.36 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.15 | 0.09 | 0.04 | 0.01 | 0.21 | 0.21 |
Additional Paid-In Capital | 651.69 | 639.26 | 617.53 | 493.32 | 491.82 | 490.64 |
Retained Earnings | -650.15 | -639.98 | -649.15 | -482.63 | -463.68 | -444.72 |
Comprehensive Income & Other | -0.01 | 0.01 | -0.04 | -0.02 | -0.03 | -0.01 |
Total Common Equity | 1.69 | -0.63 | -31.63 | 10.67 | 28.31 | 46.12 |
Shareholders' Equity | 1.69 | -0.63 | -31.63 | 10.67 | 28.31 | 46.12 |
Total Liabilities & Equity | 11.47 | 10.62 | 24.96 | 22.68 | 39.37 | 55.48 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 5.02 | 3.82 | 21.34 | 20.82 | 38.76 | 55.07 |
Net Cash Growth | -61.65% | -82.10% | 2.48% | -46.28% | -29.62% | 189.46% |
Net Cash Per Share | 0.45 | 0.46 | 13.74 | 24.80 | 46.34 | 81.79 |
Filing Date Shares Outstanding | 15.26 | 10.16 | 5.07 | 0.84 | 0.84 | 0.84 |
Total Common Shares Outstanding | 15.26 | 9.07 | 3.65 | 0.84 | 0.84 | 0.84 |
Working Capital | -0.71 | -3.17 | 13.42 | 13.44 | 31.3 | 49.32 |
Book Value Per Share | 0.11 | -0.07 | -8.66 | 12.70 | 33.82 | 55.18 |
Tangible Book Value | -0.75 | -3.16 | -31.63 | 10.67 | 28.31 | 46.12 |
Tangible Book Value Per Share | -0.05 | -0.35 | -8.66 | 12.70 | 33.82 | 55.18 |
Machinery | - | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 |